H-STFKNWPFL-OH

Ref. 3D-PP47057

Produktinformation

• Name: H-STFKNWPFL-OH
• Synonyme: NH2-Ser-Thr-Phe-Lys-Asn-Trp-Pro-Phe-Leu-OH

Beschreibung

Peptide H-STFKNWPFL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-STFKNWPFL-OH include the following: Enhancement of survivin-specific anti-tumor immunity by adenovirus prime protein-boost immunity strategy with DDA/MPL adjuvant in a murine melanoma YQ Wang, HH Zhang, CL Liu, H Wu, P Wang - International , 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1567576913001513 HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer MH Andersen, RB Soerensen, JC Becker - Journal of translational , 2006 - Springerhttps://link.springer.com/article/10.1186/1479-5876-4-38 Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in J Kobayashi, T Torigoe , Y Hirohashi , S Idenoue - Journal of Translational , 2009 - Springerhttps://link.springer.com/article/10.1186/1479-5876-7-1 Fast DNA Vaccination Strategy Elicits a Stronger Immune Response Dependent on CD8+ CD11c+ Cell Accumulation C Liu, X Cong, Y Wang, Q Guo, Y Xie, F Geng - Frontiers in , 2021 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fonc.2021.752444/full Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma A Lladser , K Ljungberg, H Tufvesson, M Tazzari - Cancer immunology , 2010 - Springerhttps://link.springer.com/article/10.1007/s00262-009-0725-4

• Marke: Biosynth